| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20029779 | HPV | ENSG00000113578.18 | protein_coding | FGF1 | Yes | No | 2246 | P05230 |
| TVIS20059304 | HPV | ENSG00000113578.18 | protein_coding | FGF1 | Yes | No | 2246 | P05230 |
| TVIS44031829 | HTLV-1 | ENSG00000113578.18 | protein_coding | FGF1 | Yes | No | 2246 | P05230 |
| TVIS44025448 | HTLV-1 | ENSG00000113578.18 | protein_coding | FGF1 | Yes | No | 2246 | P05230 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | FGF1 |
|---|---|
| DrugBank ID | DB01942 |
| Drug Name | Formic acid |
| Target ID | BE0000689 |
| UniProt ID | P05230 |
| Regulation Type | |
| PubMed IDs | 17139284; 17016423 |
| Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. |
| Groups | Experimental; Investigational |
| Direct Classification | Carboxylic acids |
| SMILES | [H]C(O)=O |
| Pathways | Cerivastatin Action Pathway; Desmosterolosis; Pamidronate Action Pathway; Ibandronate Action Pathway; 17-beta Hydroxysteroid Dehydrogenase III Deficiency; DOPA-Responsive Dystonia; Simvastatin Action Pathway; Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2); Smith-Lemli-Opitz Syndrome (SLOS); Pterine Biosynthesis; Lysosomal Acid Lipase Deficiency (Wolman Disease); Steroid Biosynthesis; Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps); Hypercholesterolemia; Risedronate Action Pathway; Hyperphenylalaniemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency; Mevalonic Aciduria; Tryptophan Metabolism; Rosuvastatin Action Pathway; Alendronate Action Pathway; Zoledronate Action Pathway; Cholesteryl Ester Storage Disease; Androgen and Estrogen Metabolism; Lovastatin Action Pathway; Folate Metabolism; Aromatase Deficiency; Methylenetetrahydrofolate Reductase Deficiency (MTHFRD); Fluvastatin Action Pathway; Atorvastatin Action Pathway; Pravastatin Action Pathway |
| PharmGKB | PA449705 |
| ChEMBL | CHEMBL116736 |
